About us
Who we are
Our strategy
How we are funded
Our people
Governance and structure
Reports and statements
Suppliers
Our strategy
Our strategy
Global health
Neurodegeneration
Rare Disease
Respiratory health
Working with us
Support for MRC researchers
Helping charities
Our partners
Available technologies
Advise & Connect: Covid-19
Funding
LifeArc Ventures
Rare disease translational challenges
Development Gap Fund
Current funding opportunities
Capabilities
Drug discovery
Antibody humanisation
IP management and technology transfer
Diagnostics development
Careers
Working at LifeArc
Our culture
Benefits and rewards
Students and fellows
How to apply
Job vacancies
News
Latest news
Case studies
Reports and publications
Newsletter
Respiratory health
More than 3.9 million people died from respiratory disease in 2017
Home
Our strategy
Respiratory health
We’re investing over £100m to tackle respiratory infections.
Chronic Respiratory Infection Translational Challenge
Find out about our £100m programme to accelerate scientific innovation for people living with bronchiectasis and cystic fibrosis.
£3m fund to accelerate development of new CF therapies
CF AMR Syndicate’s Collaborative Discovery Programme will support approximately five collaborative projects.
Repurposing Call For Chronic Respiratory Infection
Applications to this call are now closed. Information on the timeline and next steps is available here.
Resources
Resources for academics and patient groups researching solutions for bronchiectasis and cystic fibrosis.
COVID-19
Read about our £27m programme to deepen understanding and develop new treatments to protect people against COVID-19
Contact
Get in touch with LifeArc